eli lilly clinical trials tirzepatide New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Eli Lilly is one step

Compounded Tirzepatide for Effective, Affordable Weight Loss Expert-guided weight loss with fast access to oral and injectable GLP-1 medications designed to help you see results, sooner

Although Im still about 25 pounds away from goal, with the encouragement and motivation I continue to Lisa A., Age 55

Stimulant content: L-Carnitine is stimulant-free

Even more concerning, girls and mothers have told me they are turning to GLP-1s for shidduchim, to quickly lose weight before dating or a simcha, to appear more desirable to a partner, or simply to meet community and family expectations about body size

These results hold in telehealth and in-person settings